| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |